272 related articles for article (PubMed ID: 18349137)
1. Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis.
Desjardins F; Lobysheva I; Pelat M; Gallez B; Feron O; Dessy C; Balligand JL
Cardiovasc Res; 2008 Aug; 79(3):527-36. PubMed ID: 18349137
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.
Pelat M; Dessy C; Massion P; Desager JP; Feron O; Balligand JL
Circulation; 2003 May; 107(19):2480-6. PubMed ID: 12719275
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
4. Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells.
Shen J; Lee W; Li Y; Lau CF; Ng KM; Fung ML; Liu KJ
J Neurochem; 2008 Oct; 107(2):478-87. PubMed ID: 18717816
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the circadian clock gene Per2 alters vascular endothelial function.
Viswambharan H; Carvas JM; Antic V; Marecic A; Jud C; Zaugg CE; Ming XF; Montani JP; Albrecht U; Yang Z
Circulation; 2007 Apr; 115(16):2188-95. PubMed ID: 17404161
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells.
Pan YM; Yao YZ; Zhu ZH; Sun XT; Qiu YD; Ding YT
Acta Pharmacol Sin; 2006 Dec; 27(12):1567-74. PubMed ID: 17112410
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice.
Wunderlich C; Schober K; Kasper M; Heerwagen C; Marquetant R; Ebner B; Forkmann M; Schoen S; Braun-Dullaeus RC; Schmeisser A; Strasser RH
Biochem Biophys Res Commun; 2008 Dec; 377(3):769-74. PubMed ID: 18951881
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells.
Maniatis NA; Brovkovych V; Allen SE; John TA; Shajahan AN; Tiruppathi C; Vogel SM; Skidgel RA; Malik AB; Minshall RD
Circ Res; 2006 Oct; 99(8):870-7. PubMed ID: 16973909
[TBL] [Abstract][Full Text] [Related]
9. Effect of NO synthase inhibition on cardiovascular circadian rhythms in wild-type and eNOS-knock-out mice.
Lemmer B; Arraj M
Chronobiol Int; 2008 Jul; 25(4):501-10. PubMed ID: 18622812
[TBL] [Abstract][Full Text] [Related]
10. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice.
Leonard AM; Chafe LL; Montani JP; Van Vliet BN
Am J Hypertens; 2006 Dec; 19(12):1264-9. PubMed ID: 17161773
[TBL] [Abstract][Full Text] [Related]
11. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice.
Lam TY; Seto SW; Lau YM; Au LS; Kwan YW; Ngai SM; Tsui KW
Eur J Pharmacol; 2006 Sep; 546(1-3):134-41. PubMed ID: 16904102
[TBL] [Abstract][Full Text] [Related]
12. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation.
Bucci M; Gratton JP; Rudic RD; Acevedo L; Roviezzo F; Cirino G; Sessa WC
Nat Med; 2000 Dec; 6(12):1362-7. PubMed ID: 11100121
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
14. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
[TBL] [Abstract][Full Text] [Related]
15. Vascular caveolin deficiency supports the angiogenic effects of nitrite, a major end product of nitric oxide metabolism in tumors.
Frérart F; Lobysheva I; Gallez B; Dessy C; Feron O
Mol Cancer Res; 2009 Jul; 7(7):1056-63. PubMed ID: 19567781
[TBL] [Abstract][Full Text] [Related]
16. Polyphenol-containing azuki bean (Vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension.
Mukai Y; Sato S
Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):491-7. PubMed ID: 19157815
[TBL] [Abstract][Full Text] [Related]
17. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 deficiency increases cerebral ischemic injury.
Jasmin JF; Malhotra S; Singh Dhallu M; Mercier I; Rosenbaum DM; Lisanti MP
Circ Res; 2007 Mar; 100(5):721-9. PubMed ID: 17293479
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of endothelial nitric oxide synthase and caveolin-1 in the aorta of rats with isoproterenol-induced cardiac hypertrophy.
Krenek P; Klimas J; Kroslakova M; Gazova A; Plandorova J; Kucerova D; Fecenkova A; Svec P; Kyselovic J
Can J Physiol Pharmacol; 2006 Dec; 84(12):1245-50. PubMed ID: 17487232
[TBL] [Abstract][Full Text] [Related]
20. Moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells.
Lobysheva I; Rath G; Sekkali B; Bouzin C; Feron O; Gallez B; Dessy C; Balligand JL
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2098-105. PubMed ID: 21659644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
